This article was originally published in The Rose Sheet
Analyst report and media coverage of potential merger of Colgate-Palmolive and Gillette results in Colgate 2-7/16 stock increase to 57 - a 4.5% jump - on June 7. Gillette stock rose 1/8 to 34-7/8. Following an earlier report from Goldman, Sachs VP Amy Chasen speculating on the merger and an initial Wall Street Journal article June 2, Colgate stock rose 1-1/16 to 54-1/2 and Gillette inched up 13/16 to 35-9/16. Although the probability of a Colgate/Gillette union is unlikely, Gillette's strong brands and market exposure could make the company an attractive buy (1"The Rose Sheet" Jan. 31, p. 11). If Colgate places a bid for Gillette, it potentially would not be the first personal care products company to show an interest; Procter & Gamble is understood to have sent a proposition to Gillette early this year
You may also be interested in...
Gillette's market vulnerability and the recent heavy merger activity among pharmaceutical diversifieds may make the company a potential acquisition target.
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle